Literature DB >> 32287067

Psychiatric trajectories across adolescence in perinatally HIV-exposed youth: the role of HIV infection and associations with viral load.

Nadia Nguyen1, C Jean Choi1, Reuben Robbins1, Rehema Korich1, Jeanette Raymond1, Curtis Dolezal1, Cheng-Shiun Leu1, Andrew Wiznia2, Elaine J Abrams3, Claude A Mellins1.   

Abstract

OBJECTIVE: Identify factors associated with trajectories of psychiatric disorder among 340 adolescents and young adults (AYA) living with perinatal HIV infection (PHIV) and perinatal HIV-exposure but not infection (PHEU).
DESIGN: Longitudinal cohort study of AYA in New York City, 9-16 years at enrollment.
METHODS: We used multivariate longitudinal latent class analysis to identify trajectories of psychiatric disorder, and logistic regression to examine predictors of trajectories (e.g. PHIV status) and associations between trajectories and viremia in young adulthood (AYA with PHIV only).
RESULTS: Among all AYA, we identified three psychiatric trajectories: relatively 'low disorder' (63%), 'consistent anxiety' (26%), and 'escalating comorbidity' (11%). Compared with AYA with 'low disorder', AYA with 'escalating comorbidity' were significantly older, reported more neighborhood stress, and lived with a caregiver with alcohol use disorder, whereas AYA with 'consistent anxiety' were more likely female individuals. Although we found no statistically significant HIV status differences, among AYA with PHIV, nearly half (48%) were viremic in young adulthood, with higher odds of viremia among AYA with 'escalating comorbidity' (OR: 3.88, 95% CI: 0.93-16.26) and 'consistent anxiety' (OR: 2.41, 95% CI: 1.011-5.75) compared with 'low disorder'.
CONCLUSION: Despite significant adversity, AYA with PHIV and PHEU had relatively low prevalence of psychiatric disorder over time, although one-third had consistent or escalating psychiatric disorders. Among AYA with PHIV, psychiatric trajectories were associated with viremia in young adulthood. Given the growing population of AYA living with PHIV and PHEU worldwide, addressing the substantial and evolving mental health needs of both groups as they reach young adulthood is critical.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32287067      PMCID: PMC7554128          DOI: 10.1097/QAD.0000000000002529

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  45 in total

Review 1.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

2.  Screening depressed patients in family practice. A rapid technic.

Authors:  A T Beck; R W Beck
Journal:  Postgrad Med       Date:  1972-12       Impact factor: 3.840

3.  Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure.

Authors:  Kathleen M Malee; Katherine Tassiopoulos; Yanling Huo; George Siberry; Paige L Williams; Rohan Hazra; Renee A Smith; Susannah M Allison; Patricia A Garvie; Betsy Kammerer; Suad Kapetanovic; Sharon Nichols; Russell Van Dyke; George R Seage; Claude A Mellins
Journal:  AIDS Care       Date:  2011-12

4.  Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.

Authors:  Brian Wells Pence; William C Miller; Bradley N Gaynes; Joseph J Eron
Journal:  J Acquir Immune Defic Syndr       Date:  2007-02-01       Impact factor: 3.731

5.  The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study.

Authors:  D Shaffer; P Fisher; M K Dulcan; M Davies; J Piacentini; M E Schwab-Stone; B B Lahey; K Bourdon; P S Jensen; H R Bird; G Canino; D A Regier
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-07       Impact factor: 8.829

6.  Exposure to Violence and Virologic and Immunological Outcomes Among Youth With Perinatal HIV in the Pediatric HIV/AIDS Cohort Study.

Authors:  Deborah Kacanek; Kathleen Malee; Claude A Mellins; Katherine Tassiopoulos; Renee Smith; Mitzie Grant; Sonia Lee; Danish Q Siddiqui; Ana Puga
Journal:  J Adolesc Health       Date:  2016-04-15       Impact factor: 5.012

7.  Stressful life events and their relationship to psychological and medical functioning in children and adolescents with HIV infection.

Authors:  Deborah K Elliott-DeSorbo; Staci Martin; Pamela L Wolters
Journal:  J Acquir Immune Defic Syndr       Date:  2009-11-01       Impact factor: 3.731

8.  Relationships Between Demographic, Clinical, and Health Care Provider Social Support Factors and Internalized Stigma in People Living With HIV.

Authors:  Nara Jang; Suzanne Bakken
Journal:  J Assoc Nurses AIDS Care       Date:  2016-09-05       Impact factor: 1.354

9.  DISADVANTAGED NEIGHBORHOOD INFLUENCES ON DEPRESSION AND ANXIETY IN YOUTH WITH PERINATALLY ACQUIRED HUMAN IMMUNODEFICIENCY VIRUS: HOW LIFE STRESSORS MATTER.

Authors:  Ezer Kang; Claude A Mellins; Curtis Dolezal; Katherine S Elkington; Elaine J Abrams
Journal:  J Community Psychol       Date:  2011-10-11

10.  Assessing efficacy of a retention-in-care intervention among HIV patients with depression, anxiety, heavy alcohol consumption and illicit drug use.

Authors:  Lytt I Gardner; Gary Marks; Lokesh Shahani; Thomas P Giordano; Tracey E Wilson; Mari-Lynn Drainoni; Jeanne C Keruly; David Scott Batey; Lisa R Metsch
Journal:  AIDS       Date:  2016-04-24       Impact factor: 4.177

View more
  1 in total

1.  Racial/Ethnic Disparities in Longitudinal Emotional-Behavioral Functioning Among Youth Born to Women Living With HIV.

Authors:  Jemar R Bather; Paige L Williams; Carly Broadwell; Renee Smith; Kunjal Patel; Patricia A Garvie; Brad Karalius; Deborah Kacanek; Claude A Mellins; Kathleen Malee
Journal:  J Acquir Immune Defic Syndr       Date:  2021-07-01       Impact factor: 3.771

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.